Edoardo Botteri

ORCID: 0000-0002-9023-8068
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Screening and Detection
  • Breast Lesions and Carcinomas
  • Gastric Cancer Management and Outcomes
  • Breast Implant and Reconstruction
  • Estrogen and related hormone effects
  • Global Cancer Incidence and Screening
  • Cancer Genomics and Diagnostics
  • Cancer, Stress, Anesthesia, and Immune Response
  • Genetic factors in colorectal cancer
  • Cancer Risks and Factors
  • Cancer Cells and Metastasis
  • Cancer, Lipids, and Metabolism
  • Inflammatory mediators and NSAID effects
  • Nutritional Studies and Diet
  • Colorectal Cancer Surgical Treatments
  • HER2/EGFR in Cancer Research
  • Lung Cancer Research Studies
  • Neuroendocrine Tumor Research Advances
  • Cutaneous Melanoma Detection and Management
  • Cancer Treatment and Pharmacology
  • Alcohol Consumption and Health Effects
  • Skin Protection and Aging
  • Lung Cancer Treatments and Mutations
  • Esophageal Cancer Research and Treatment

Cancer Registry of Norway
2016-2025

Norwegian Institute of Public Health
2024-2025

European Institute of Oncology
2010-2023

Posten (Norway)
2023

Oslo University Hospital
2016-2022

University of Oslo
2022

Italian Institute of Technology
2018

Hexal (Germany)
2018

Nasjonalt Kunnskapssenter for Helsetjenesten
2017

Ripamonti
2009-2016

Chronic stress induces signalling from the sympathetic nervous system (SNS) and drives cancer progression, although pathways of tumour cell dissemination are unclear. Here we show that chronic restructures lymphatic networks within around tumours to provide for escape. We VEGFC derived cells is required induce remodelling this depends on COX2 inflammatory macrophages. Pharmacological inhibition SNS blocks effect in vivo reduces metastasis preclinical models patients with breast cancer. These...

10.1038/ncomms10634 article EN cc-by Nature Communications 2016-03-01

Beta-adrenergic blockade has been associated with improved cancer survival in patients triple-negative breast (TNBC), but the mechanisms of these effects remain unclear. In clinical epidemiological analyses, we identified a relationship between beta-blocker use and anthracycline chemotherapy protecting against TNBC progression, disease recurrence, mortality. We recapitulated effect beta-blockade on efficacy xenograft mouse models TNBC. metastatic 4T1.2 MDA-MB-231 TNBC, doxorubicin by...

10.1126/scitranslmed.adf1147 article EN Science Translational Medicine 2023-04-26

Preclinical and retrospective studies showed that β-blockers inhibit angiogenesis disrupt migration of melanoma cells via inhibition noradrenaline-dependent responses.To study the clinical effectiveness β-blocker therapy in patients with to determine whether propranolol improves progression-free survival melanoma.We conducted a prospective treated for our center off-label use. Patients histologically confirmed stage IB IIIA cutaneous no evidence metastasis were eligible study. At time...

10.1001/jamaoncol.2017.2908 article EN JAMA Oncology 2017-10-03

According to World Health Organization (WHO) estimates, Kuwait is ranked amongst the top countries in world obesity prevalence. This study aims describe prevalence of overweight, obesity, and various types adiposity Kuwaiti adults.

10.3389/fendo.2019.00449 article EN cc-by Frontiers in Endocrinology 2019-07-09
Coming Soon ...